Uptake and degradation of hyaluronan in lymphatic tissue - Wikidata - awgldk - TriplyDB

Uptake and degradation of hyaluronan in lymphatic tissue

Uptake and degradation of hyaluronan in lymphatic tissue

http://www.wikidata.org/entity/Q34170429

about

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium Control of the molecular degradation of hyaluronic acid hydrogels for tissue augmentation.Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly.Extracellular processing of the cartilage proteoglycan aggregate and its effect on CD44-mediated internalization of hyaluronan LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.Binding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan Organization Markers of cartilage metabolism in arthrosis. A review.Primary murine airway smooth muscle cells exposed to poly(I,C) or tunicamycin synthesize a leukocyte-adhesive hyaluronan matrix Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomas Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation.Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate.Renal interstitial hyaluronan: functional aspects during normal and pathological conditions.Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE).Modeling and characterization of inflammatory breast cancer emboli grown in vitro.Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.Hyaluronan enters keratinocytes by a novel endocytic route for catabolism.Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1 Hyaluronidase 1 and β-hexosaminidase have redundant functions in hyaluronan and chondroitin sulfate degradation.Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum.Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan.Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models.Elevated hyaluronan blood concentrations in severely burned patients.Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.Filtration rate dependence of hyaluronan reflection by joint-to-lymph barrier: evidence for concentration polarisation.Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.The effect of molecular weight on the biodistribution of hyaluronic acid radiolabeled with 111In after intravenous administration to rats.Hyaluronidase 2 (HYAL2) is expressed in endothelial cells, as well as some specialized epithelial cells, and is required for normal hyaluronan catabolism.Hyaluronic acid modulates acute and chronic inflammation.Different synovial vasculogenic profiles of primary, rapidly destructive and osteonecrosis-induced hip osteoarthritis. An immunohistochemistry study.Serum hyaluronan is increased in malignant lymphoma.Properties and degradation of selected polysaccharides: hyaluronan and chitosan

P2860

Q22008808-3D8C26F2-C305-495E-809D-E21FE14255E3 Q24533666-91786D95-D537-43F3-B39C-3E37B54EC7B1 Q26786070-9940FFA0-EEC4-4787-BD8B-2F7EC19B93BF Q26795763-C10AC8B4-13D2-4D99-AC92-38567E2C0E91 Q28593262-B2F4EC88-384E-40B8-8483-5F7425025BEF Q31137026-A1AE1F4F-2C8A-4599-A32C-EE8631630977 Q34087323-1A9B9D78-B148-44E4-8162-555C3D3BEA1C Q35211796-BCB51C70-6767-4EC7-A11E-84EB86A20A50 Q35351732-8EFCFC5C-5D66-4F2F-8EBA-B2F495D915A5 Q35588306-282FD77F-51B3-4FC9-9786-1D22476A1ECF Q36778808-8501743D-A5E3-49F2-AD8A-AA7A7E6548A1 Q36901731-17DEFE5C-D0A8-4F2A-8C43-EA899B5F3336 Q37099180-80ED10DD-2D7E-4B70-B5F0-194898F64FD1 Q37186800-6A27987A-9B0E-4DC0-B070-A7AAA099E3E2 Q37545580-97BD2550-EB7F-4340-954C-6AC2675D1277 Q37563823-9EBD2F8E-14E8-4EFC-9514-3A9016D11604 Q38003572-7D530569-9DC3-4E17-A411-81A5585A82B2 Q38351225-6820E5C2-A611-4E6F-990E-0F07793C5E68 Q39248988-B5102FA4-F5B1-46A8-971E-313149FD2791 Q40075880-C8A30DA7-DB42-436B-A734-6E745DE7CF4D Q41642217-6F3EDE64-B679-4967-BD9A-1B8F030A18A4 Q41919323-277A3713-18B4-4CB6-BC08-0F7D3B3CDB1B Q41936261-8F2CF7B3-EA7A-422B-BAE4-5E7A071D6B49 Q42160635-57D30D2B-1F56-4CD8-A27C-F8EEF4377205 Q42463498-E29A4B85-B692-4A5B-8D75-6C00C9919E3E Q42805321-7EA6BE84-C83B-4B98-9FC1-1A64E1C4EC54 Q43576740-58D5DC8F-521B-4B94-89F9-5FC9AF2ADB1D Q43984643-E9CCCB2F-D7C2-4295-82FC-C254F42AA385 Q44530063-7DE44D89-AB09-4CE7-AB8D-F15A93D77834 Q44541251-5643A89F-2254-485A-82A7-1906B06D6DA7 Q44836777-AF516A70-A075-4A5D-A57D-20C98957A037 Q45073531-76071381-0C7B-4A20-B761-BAA6043C87CE Q45411008-5368C3D2-1B41-46B4-980D-87E5F76A124B Q45780322-0A017992-F4A4-4362-A5A1-4C1E2707C992 Q46248676-954EF067-A852-43D6-BEE8-2DE093D69A49 Q48111974-69F9D926-D5BE-49A5-BF47-A68E9AF0B36D Q49241357-A3D86448-409E-48A8-B9DC-14E6C99A5C81 Q52845617-2437890E-D8A3-452F-82D0-446BE6F230F5 Q54157248-0A7FE842-96AC-4945-8468-D310E624938C Q57371047-F188F0A2-2381-41A7-84DB-1D92B284CF28

P2860

Uptake and degradation of hyaluronan in lymphatic tissue

http://www.wikidata.org/entity/Q34170429

description

1988 nî lūn-bûn

@nan

1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Uptake and degradation of hyaluronan in lymphatic tissue

@ast

Uptake and degradation of hyaluronan in lymphatic tissue

@en

Uptake and degradation of hyaluronan in lymphatic tissue

@nl

type

label

Uptake and degradation of hyaluronan in lymphatic tissue

@ast

Uptake and degradation of hyaluronan in lymphatic tissue

@en

Uptake and degradation of hyaluronan in lymphatic tissue

@nl

prefLabel

Uptake and degradation of hyaluronan in lymphatic tissue

@ast

Uptake and degradation of hyaluronan in lymphatic tissue

@en

Uptake and degradation of hyaluronan in lymphatic tissue

@nl

P1433

Q34170429-3783C913-6B5E-41F9-AAE9-4B9B2E809B60

P1476

Q34170429-CB221189-72A8-4120-A6A3-FFD63614ECB9

P2093

Q34170429-066BACAA-C822-4D08-A5B8-50DC8E1945C8

Q34170429-433A42D5-7F33-4351-AEEC-9B4778A1F1DC

Q34170429-60D6B0B9-BD00-497E-B1C4-D1AFA0938EC2

Q34170429-6F6FF57C-836F-43FE-B467-AF9DAFCE1C64

Q34170429-8517EDAE-A4DF-46BF-A372-5E7AEB3E4A89

P2860

Q34170429-0C986208-90CC-4594-8A14-72369DEFB50D

Q34170429-1B1207F8-5C8A-4B00-84B5-D38F3E6BFD1D

Q34170429-20107737-E60C-4180-8711-A69911800469

Q34170429-287F0C06-CA1A-4A30-A58D-BF599EC8BF41

Q34170429-4F19D9B3-3809-47DB-87F6-BE007CD4B2C7

Q34170429-59A04F16-6FC8-405D-AF86-C3B553ED1EB0

Q34170429-8C0B7D13-06CB-4A2E-9414-EBB289E9E574

Q34170429-EEB9A21E-CA5C-4A80-BB21-6E74B71198E5

Q34170429-F5853668-D2C0-48E2-9EA5-C9715A07B281

P304

Q34170429-0C63C2C3-B4FF-4E79-BCC5-F1F8A00E34C1

P31

Q34170429-A07F8CB0-6130-453C-9F93-F1ED4150AC6A

P356

Q34170429-9F28C3A5-7243-40D8-8157-46944992DF80

P407

Q34170429-15485DBC-2929-49A7-A408-ED5B3020A54A

P433

Q34170429-62A93422-A7AF-4189-9B84-4465F0A71884

P478

Q34170429-34CC3ACC-360C-43FB-9A56-C2D7D0D022DC

P577

Q34170429-C8A0DD3F-EAF5-4DA5-9391-6095683701B3

P5875

Q34170429-4855B06C-3652-4502-99FA-96D751F1E0E0

P698

Q34170429-7CE0FAF6-5531-47E4-B880-178984024B04

P932

Q34170429-D43C306A-5D7A-47F0-911A-648F3C7F2AB2

P356

P1433

Biochemical Journal

P1476

Uptake and degradation of hyaluronan in lymphatic tissue

@en

P2093

Cahill RN

http://www.w3.org/2001/XMLSchema#string

Fraser JR

http://www.w3.org/2001/XMLSchema#string

Kimpton WG

http://www.w3.org/2001/XMLSchema#string

Laurent TC

http://www.w3.org/2001/XMLSchema#string

Vakakis N

http://www.w3.org/2001/XMLSchema#string

P2860

Plaque formation and isolation of pure lines with poliomyelitis viruses

Distribution of biologically labelled radioactive hyaluronic acid injected into joints.

THE ORIGIN OF THE CELLS IN THE EFFERENT LYMPH FROM A SINGLE LYMPH NODE.

The flow of blood to lymph nodes and its relation to lymphocyte traffic and the immune response.

Binding of hyaluronate and chondroitin sulphate to liver endothelial cells.

Concentration and relative molecular mass of hyaluronate in lymph and blood.

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit.

The molecular weight of hyaluronate in the aqueous humour and vitreous body of rabbit and cattle eyes.

Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study.

P304

153-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ2560153

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

256

http://www.w3.org/2001/XMLSchema#string

P577

1988-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19932196

http://www.w3.org/2001/XMLSchema#string

P698

3223897

http://www.w3.org/2001/XMLSchema#string

P932

1135381

http://www.w3.org/2001/XMLSchema#string